Foresite Capital Management IV as of June 30, 2019
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 20 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Turning Point Therapeutics I | 21.1 | $75M | 1.8M | 40.70 | |
| Insmed (INSM) | 11.3 | $40M | 1.6M | 25.60 | |
| Ascendis Pharma A S (ASND) | 8.0 | $28M | 245k | 115.15 | |
| Aerie Pharmaceuticals | 6.7 | $24M | 801k | 29.55 | |
| Alector (ALEC) | 6.1 | $22M | 1.1M | 19.00 | |
| Cytokinetics (CYTK) | 6.0 | $21M | 1.9M | 11.25 | |
| Biohaven Pharmaceutical Holding | 5.3 | $19M | 430k | 43.79 | |
| Cymabay Therapeutics | 5.2 | $18M | 2.6M | 7.16 | |
| Replimune Group (REPL) | 5.1 | $18M | 1.2M | 14.66 | |
| Optinose (OPTN) | 5.0 | $18M | 2.5M | 7.08 | |
| Voyager Therapeutics (VYGR) | 4.1 | $15M | 537k | 27.22 | |
| Myokardia | 3.6 | $13M | 258k | 50.14 | |
| Rhythm Pharmaceuticals (RYTM) | 2.9 | $10M | 470k | 22.00 | |
| Medicines Company | 2.6 | $9.1M | 250k | 36.47 | |
| Ngm Biopharmaceuticals | 1.9 | $6.9M | 471k | 14.64 | |
| Veracyte (VCYT) | 1.6 | $5.7M | 200k | 28.51 | |
| Immunomedics | 1.5 | $5.4M | 386k | 13.87 | |
| Si-bone (SIBN) | 1.2 | $4.2M | 206k | 20.34 | |
| Arbutus Biopharma (ABUS) | 0.4 | $1.3M | 608k | 2.08 | |
| Kiniksa Pharmaceuticals | 0.2 | $866k | 64k | 13.55 |
